Provided by Tiger Trade Technology Pte. Ltd.

AIM VACCINE

1.760
-0.140-7.37%
Volume:633.00K
Turnover:1.12M
Market Cap:2.16B
PE:-3.20
High:1.890
Open:1.850
Low:1.735
Close:1.900
52wk High:5.450
52wk Low:1.200
Shares:1.23B
HK Float Shares:507.67M
Volume Ratio:0.87
T/O Rate:0.12%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.550
ROE:-22.72%
ROA:-1.87%
PB:0.67
PE(LYR):-3.20
PS:1.59

Loading ...

AIM Vaccine shareholders approve bylaw amendments effective upon NEEQ listing

Reuters
·
Jun 10

AIM Vaccine books RMB525.83 million impairment after suspending mRNA rabies projects and delaying PCV13 launch

Bulletin Express
·
Jun 05

AIM Vaccine Calls 10 June 2026 EGM to Approve Private RMB Share Placement and NEEQ Listing Plan

Bulletin Express
·
May 21

AIM Vaccine announces first extraordinary general meeting

Reuters
·
May 21

AIM Vaccine Announces Resignation of Independent Non-Executive Director

Stock News
·
May 18

AIM Vaccine announces annual general meeting

Reuters
·
May 18

AIM Vaccine independent director Wen Jie resigns amid board reshuffle plan

Reuters
·
May 18

AIM Vaccine Releases 2025 ESG Report: Revenue at RMB 1.17 Billion, RMB 356 Million R&D Spend, Net-Zero Roadmap Outlined

Bulletin Express
·
Apr 27

AIM Vaccine publishes 2025 ESG report

Reuters
·
Apr 27

AIM Vaccine深化研发布局与治理架构调整,2025年营收约人民币11.65673亿元亏损扩大

Bulletin Express
·
Apr 27

AIM VACCINE Shares Surge Over 5% on Plan to List on Beijing Stock Exchange and Imminent Launch of World's First Serum-Free Rabies Vaccine

Stock News
·
Apr 15

Stock Track | AIM VACCINE Soars 6.78% Intraday on Plans for Beijing Stock Exchange A-Share Listing

Stock Track
·
Apr 02

AIM VACCINE Shares Surge Nearly 8% on Plan to List A-Shares on Beijing Stock Exchange

Stock News
·
Apr 02

AIM Vaccine Seeks Dual Listing on Beijing Stock Exchange

Stock News
·
Mar 31

BRIEF-AIM Vaccine Approves Issuance Of Up To 40 Million Domestic Shares

Reuters
·
Mar 30

AIM Vaccine Co - Approves Issuance of up to 40 Mln Domestic Shares

THOMSON REUTERS
·
Mar 30

AIM Vaccine FY25 loss attributable to owners widens 143.6% to RMB 680 million; revenue falls 9.3% to RMB 1.2 billion

Reuters
·
Mar 30

AIM Vaccine Co Ltd - FY Loss Attributable RMB675.5 Mln

THOMSON REUTERS
·
Mar 30

Hong Kong-listed AIM Vaccine (06660) schedules 30 March 2026 board meeting to approve FY2025 results and consider final dividend

Bulletin Express
·
Mar 18